GlassScriptPhysician profile
Kimberly D Goad
NPI 1841289386
$2,729.63
in general payments reported to CMS, 2019-2025
13 companies · $591 in 2025
The $591 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $813 · 2022: $197 · 2023: $556 · 2024: $572 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,704 · Education: $16.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,703.58 |
| Education | $16.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $833.50 | 2023-2025 | Coroflow, Optis, Diamondback Coronary |
| Janssen Pharmaceuticals, INC | $398.30 | 2021-2022 | |
| Medtronic, INC. | $344.73 | 2021-2025 | Symplicity G3, Onyx Frontier, Minimed 780g |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $289.68 | 2021-2022 | |
| Boston Scientific Corporation | $247.31 | 2021-2025 | Watchman Flx, Resonate El Icd Vr |
| Inspire Medical Systems, INC. | $173.54 | 2024-2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $125.81 | 2021-2023 | Camzyos |
| W. L. Gore & Associates, INC. | $116.50 | 2024 | Gore Cardioform Septal Occluder |
| Philips North America LLC | $67.10 | 2023 | |
| Terumo Medical Corporation | $52.04 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.18 | 2022 | |
| Merck Sharp & Dohme LLC | $30.60 | 2021-2022 | |
| Pfizer INC. | $15.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Goad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.